According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

the single-dose nasal spray is designed to be administered into one nostril, and was approved for use in adults and kids who weigh at least 66 pounds with severe allergies. Related: FDA approves ...

The Neffy nasal spray uses the same formula used in the traditional Epinephrine injection as a treatment for mild to severe ...

On 9 August, US health officials approved the first nasal spray to treat allergic ... of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and ...

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

Allergy and Critical Care in the FDA's Center for Drug Evaluation and Research, said in an agency statement. "The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

The Food and Drug Administration approved Friday a nasal spray for serious ... injections," Kelly Stone, FDA's associate director of the Division of Pulmonology, Allergy and Critical Care, said ...

The FDA just approved an epinephrine nasal ... the vice president of community at the Asthma and Allergy Foundation of America. “Nasal epinephrine spray may remove some of the barriers that ...

a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...

The US Food and Drug Administration (FDA) has approved the first nasal medicine to treat severe allergies. On 9 August, US health officials approved the first nasal spray to treat allergic ...